ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,697,301, issued on Aug. 4, was assigned to TRANSLATE BIO INC. (Waltham, Mass.).
"Pulmonary delivery of mRNA to non-lung target cells" was invented by Michael Heartlein (Lexington, Mass.), Braydon Charles Guild (Lexington, Mass.), Frank DeRosa (Lexington, Mass.), Carsten Rudolph (Martinsried, Germany) and Christian Plank (Martinsried, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions comprising mRNA formulated for pulmonary administration and related methods for delivery of the mRNA and/or encoded protein to a non-lung cell or tissue. The compositions and methods may be used to prevent or ameliorate the symptoms of diseases associated wi...